About Joslin | Patient Care | Supporting Joslin
This study aims to collect high quality glycemic information from persons with type 1 diabetes using meal challenges.
This study seeks to determine the effects of aging and type 2 diabetes mellitus on blood flow velocity and levels of oxygen in the brain, and how these changes influence one's balance when standing with and without a secondary task.
The purpose of this study is to better understand the effect of exercise training on your adipose (fat) tissue.
The purpose of this study is to study the effects of aerobic exercise training on circulating proteins secreted from fat and muscle tissue in a healthy population.
The purpose of this study is to demonstrate whether,
in addition to standard of care (SoC), finerenone is superior to placebo in
delaying the progression of kidney disease.
The purpose of this study is to demonstrate whether finerenone
is superior to placebo in delaying the time to first occurrence of cardiovascular mortality in subjects with Type 2 Diabetes Mellitus and clinical
diagnosis of diabetic kidney disease.
The purpose of this study is to test if a continuous glucose monitor (CGM) can detect and help
prevent hypoglycemia (low blood sugar) in individuals who have post-bariatric
surgery hypoglycemia syndrome.
The purpose of this study is to find out if patterns of microbiome composition (bacteria in your stool) are related to how glucose levels change after a meal in patients with hypoglycemia (low blood sugar).
The purpose of this study is to examine the mechanisms through with genetic factors may predispose people with diabetes to cardiovascular (heart) disease.
The purpose of this study is to determine whether a man's metabolic health, including diabetes and body weight, can affect signals in his sperm which affect how genes are turned on or off.
This study is evaluating the accuracy of an investigational device (not FDA approved yet) called LabPatch Continuous Glucose Monitor by comparing it to a laboratory glucose analyser called YSI, and 2 commercial glucose meters.
This study uses an electronic dose-recording device to examine dosing in individuals on multiple daily insulin injections.
This study examines the effect that mobile health technology has on promoting lifestyle changes in adults with type 2 diabetes.
This study assesses a new technology that aids the communication of health information amongst patients, family members/caregivers, and providers.
The study aims to identify youth and adults at risk for type 1 diabetes by testing for diabetes-related antibodies in relatives of people with type 1 diabetes.
In this clinical research study we are evaluating whether supplementation of a naturally occurring component found in beets and other vegetables and grains reduces diabetes risk.
The purpose of this study is to compare the effects of low fat and full fat dairy products on blood sugar control in people with type 2 diabetes.
The purpose of this study is to look at the effects of the study
interventions in the DPP on the development of type 2 diabetes as well as
diabetes related health problems and cancer diagnosis over a longer period of
The purpose of this
study is to study the development of the major long-term
complications of type 1 diabetes among the volunteers who participated in the
Diabetes Control and Complication Trial (DCCT) and the first twelve years of
the Epidemiology of Diabetes Interventions and Complications Study (EDIC).
This study is designed to test if the drug tocilizumab can help preserve or delay destruction of remaining beta cells in people recently diagnosed with type 1 diabetes.
This study will explore parental attitudes toward diabetes management in young children.
The purpose of this study is to test if a continuous glucose sensor linked to a computer and a pump can provide a low dose of glucagon to prevent hypoglycemia after a liquid meal in individuals who have hypoglycemia after gastric bypass.
This study will explore attitudes toward diabetes technology and automated insulin delivery.
We are looking for volunteers to help us find out more about usability of a proposed automated insulin delivery system named inControl.
The purpose of this study is to understand the long-term effects of weight change on overall health in the cohort of the original Look AHEAD study.
The purpose of the "Monitoring Autoimmunity in Diabetes" study is to look at changes in the body that may occur with the development of type 1 diabetes.
The purpose of this study is to determine the effect of meal replacement shakes on blood sugar control in people who have type 2 diabetes and are overweight.
The purpose of this study
is to document the presence of eye, nerve and kidney complications related to
diabetes, as well as to examine DNA and substances in the blood and urine of
people with diabetes for 50 years or more.
Cross-sectional study assessing patient and parent preferences for an automated, on-body insulin delivery system, using semi-structured interviews and validated surveys in order to assist in the design of such a system.
This study will explore parent and youth attitudes toward cardiovascular risk factors such as high cholesterol or blood pressure and diabetes complications.
purpose of this study is to find out whether a medication called allopurinol
can prevent kidney problems, in particular the loss of kidney function, in
people with type 1 diabetes.
The purpose of this trial is to study effects of an investigational drug, called Semaglutide (not FDA approved yet) that may help control blood sugar levels.
A clinical trial to find out how well the continuous glucose monitor works in children less than 8 years old with T1D and whether an added program for parents/guardians can improve comfort with using the CGM and improve blood glucose control.
The Type 1 Diabetes (T1D) Exchange is a nationwide registry collecting information about children and adults with type 1 diabetes.
This study aims to determine if the drug SIMPONI® (golimumab) can preserve beta-cell function in children and young adults with newly diagnosed type 1 diabetes.
The purpose of TODAY 2
Phase 2 is to find out if the drug treatment or lifestyle program participants received during the TODAY Study has any long- term effect on blood sugar
control or the medical complications of diabetes, like heart or kidney disease.
This study aims to assess if one's own expanded regulatory T cells can rebalance the immune system, decreasing the attack on the insulin producing cells in type 1 diabetes.